Search results for: 'formulation development'

This study presents an overview of the Asia-Pacific infectious disease point-of-care testing (POCT) market with an emphasis on some of the key trends and growth opportunities that are shaping the market. The study highlights some of the emerging business models supporting the development and adoption of innovative diagnostic tests. The Asia-Pacif...

This research service covers the revenues and trends in the Asia-Pacific (APAC) image-guided surgery (IGS) and robot-assisted surgery (RAS) market. Higher disposable income, penetration of health insurance, and improvement in overall quality of life necessitate the need for quality healthcare services. This has led to investment in assistive techno...

This study provides a comprehensive analysis of the contract research and manufacturing services (CRAMS) segment in India by focusing on drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectables. The study is based on detailed primary research, and includes an evaluation of the market size as we...

Over the past 2 years the global pharmaceutical industry has been shifting its focus towards the emerging market such as India. The CRAMS segment in India is expected to be one of the biggest beneficiaries of this wave. This study presents a comprehensive study of the Indian contract research and manufacturing services market from drug discovery t...

This research deliverable provides deep insights into the clinical development and outsourcing market in India. It also includes an overview of the Indian regulatory and R&D process briefing about the clinical trials registration process, trends in regional/local pharmaceutical and biotechnology development as well as the impact of those developmen...

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...

Chinese healthcare industry witnessed one of the fastest growths in the world in the last two decades. The growth of the healthcare industry was mainly driven by globalization initiatives and increased domestic and foreign investment after WTO accession. The government is continuously working to reform the health sector and healthcare development i...

13 Mar 2015  |  Asia Pacific  |  Market Research

Analysis of the Global Vaccines Delivery Market

Innovative Technologies and Future Trends for Stakeholders

Infographics

×

The global market for vaccines is estimated to be only 2-3% of the total pharmaceuticals market in 2014; however, this sector has been continuously experiencing a stellar growth rate of 10-15% per year versus the 5-7% seen in the overall market. Currently, the most commonly available vaccines are administered by injection, which makes mass immuniza...